September 27, 1999
AMERIPATH ACQUIRES WISCONSIN PATHOLOGY PRACTICE

Riviera Beach, FL, September 27, 1999 -- AmeriPath, Inc. (Nasdaq: PATH), a physician group practice and laboratory management company focused on anatomic pathology services, announced today that it has completed the acquisition of Associated Laboratory Physician Services, a pathology practice located in Wauwatosa, Wisconsin, approximately 10 miles west of Milwaukee. The practice had annualized net revenues, as of May 1999, of approximately $6.3 million. Terms of the transaction were not disclosed.

Associated Laboratory Physician Services and its physicians have maintained an excellent reputation in the Milwaukee area for over 40 years. This is AmeriPath's second acquisition in the state of Wisconsin and its first in the Milwaukee area. The practice's eighteen physicians provide professional pathology services for five hospitals in the Covenant Healthcare System representing over 1400 beds in addition to two labs and a closed panel HMO in the Greater Milwaukee area.

"The addition of Associated Laboratory Physician Services, with Winston N. Hollister, M.D. as Managing Director, will enhance our presence in the state of Wisconsin as a pedestal pathology practice with longstanding ties to the Milwaukee medical community," said James C. New, Chairman and CEO of AmeriPath. "This is of strategic significance to our growth in this market and complements as well as provides synergistic opportunities with the Consultant Physicians in Pathology practice located in Beaver Dam."

AmeriPath, Inc. is the nation's leading physician group practice and laboratory management company focused on providing anatomic pathology services to physicians, hospitals, national clinical laboratories, and managed care organizations. The Company presently operates in twelve states and employs 291 pathologists who provide medical services through outpatient pathology laboratories, hospital inpatient laboratories, and outpatient surgery centers.

.......................................................................................................................

This release contains certain forward-looking statements regarding AmeriPath, including its operations and prospects. Past performance is not necessarily indicative of future results. In addition, AmeriPath's actual results could differ materially from the results anticipated in these forward-looking statements as a result of uncertainties, including risks relating to demand, pricing, government regulation, payments and reimbursement, changes on reimbursement coding guidelines, dependence upon contracts and pathologists, acquisitions and affiliations, integration of acquired practices, the market for pathology services, competition, and other factors identified and discussed in AmeriPath's filings with the Securities and Exchange Commission (including its Form 10-K Annual Report).